Risk factors for hepatic decompensation in patients with primary biliary cirrhosis

Table 2 Laboratory characteristics of primary biliary cirrhosis patients at the time of entry (n = 262)

ANA	181(69.1)
AMA	245 (93.5)
ACA	73 (27.9)
ALT (IU/L)	91.0 (9-598)
AST (IU/L)	86.2 (15-428)
AST/ALT	1.10 (0.22-4.85)
ALP (IU/L)	348.5 (21-1486)
GGT (IU/L)	428.2 (9-2614)
ALB (g/L)	40.7 (25-69)
TBil (μmol/L)	28.05 (4.90-334.40)
DBil (μmol/L)	14.39 (0.34-237.40)
IgG (g/L)	16.81 (5.12-56.60)
IgA (g/L)	3.15 (0.19-8.84)
IgM (g/L)	4.66 (0.41-22.30)

Continuous data were expressed as n (%) or median (range). ANA: Anti-nuclear antibody; AMA: Anti-mitochondrial antibody; ACA: Anti-centromere antibody; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; ALP: Alkaline phosphatase; GGT: γ-glutamyl-transferase; ALB: Albumin; TBil: Total bilirubin; DBil: Direct bilirubin; Ig: Immunoglobulin.